Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a phase I/II Study of Nivolumab in Combination with 5-azacytidine in pediatric patients with relapsed/refractory acute myeloid leukemia
Epistemonikos ID: ef2ef41f22ff6796d9e917154461c7e71389842f
First added on: May 22, 2024